Press release -
Long-term documentation presented on all implant systems from DENTSPLY Implants
Documented research is essential in the development of solutions and products. DENTSPLY Implants presents long-term clinical documentation on all three implant lines—ANKYLOS, ASTRA TECH Implant System and XiVE—in the portfolio.
“I am very proud that we can present such solid long-term clinical results on all three implant systems, because it proves our commitment and dedication to science and clinical research,” says AnnaKarin Lundgren, DDS, PhD, Director Global Clinical Affairs at DENTSPLY Implants.
Long-term clinical documentation is one of the most important tools to show a product’s efficiency, reliability and safety. In the DENTSPLY Implants portfolio, the ANKYLOS implant system has been in clinical use for more than 25 years, showing excellent long-term results with up to 20 years of clinical follow-up. For ASTRA TECH Implant System, long-term clinical results up to 16 years are available, and for XiVE implant system, long-term results with up to 10 years of clinical follow-up are presented.
In addition, DENTSPLY Implants just presented new 5-year data on OsseoSpeed implants (ASTRA TECH Implant System), showing stable soft tissue and maintained bone levels from implant placement and implant loading, confirming an average bone level reduction of only 0.3 mm.
For over 40 years, DENTSPLY Implants has focused on research and development in all aspects of implant treatment, supported by extensive pre-clinical and clinical study programs.
DENTSPLY Implants’ products and solutions are well-documented with reliable clinical results, and are supported by more than 1,650 scientific publications. Currently, there are 200 ongoing studies worldwide, involving more than 450 clinicians.
Scientific references
Krebs M, Schmenger K, Neumann K, Weigl P, Moser W, Nentwig GH. Long-term evaluation of ANKYLOS® dental implants, part I: 20-year life table analysis of a longitudinal study of more than 12,500 implants. Clin Implant Dent Relat Res 2015;17 Suppl 1:e275-86.
Cooper LF, Reside GJ, Raes F, Garriga JS, Tarrida LG, Wiltfang J, Kern M, De Bruyn H. Immediate provisionalization of dental implants placed in healed alveolar ridges and extraction sockets: A 5-year prospective evaluation. Int J Oral Maxillofac Implants 2014;29(3):709-17.
Degidi M, Nardi D, Piattelli A. 10-year prospective cohort follow-up of immediately restored XiVE implants. Clin Oral Implants Res 2015, E-pub June 21.
To read more about the science behind DENTSPLY Implants’ products and solutions, please visit www.dentsplyimplants.com/science
Related links
Topics
- Health, Health Care, Pharmaceuticals
Categories
- science
- dental
- dental implants
- dentsply
- dentsply implants
- implant systems
About DENTSPLY Implants
DENTSPLY Implants offers comprehensive solutions for all phases of implant therapy, including ANKYLOS®, ASTRA TECH Implant System™ and XiVE® implant lines, digital technologies, such as ATLANTIS™ patient-specific CAD/CAM solutions and SIMPLANT® guided surgery, SYMBIOS® regenerative solutions, and professional and business development programs, such as STEPPS™. DENTSPLY Implants creates value for dental professionals and allows for predictable and lasting implant treatment outcomes, resulting in enhanced quality of life for patients.
About DENTSPLY International
DENTSPLY International Inc. is a leading manufacturer and distributor of dental and other consumable medical device products. The Company believes it is the world's largest manufacturer of consumable dental products for the professional dental market. For over 115 years, DENTSPLY's commitment to innovation and professional collaboration has enhanced its portfolio of branded consumables and small equipment. Headquartered in the United States, the Company has global operations with sales in more than 120 countries. Visit www.dentsply.com for more information about DENTSPLY and its products.
